| Target Professions: | DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Cardiology/Cardiovascular Medicine |
| Credits Available: | 4.75 hours of AMA PRA Category 1 Credit™ |
Patients who are obese or overweight are frequently seen in cardiology for other conditions and weight reduction with GLP-1 RAs can be a useful tool in the cardiologist’s toolbox. Through this program, cardiologists will become more familiar with the data supporting the use of GLP 1 RAs in their patients, identify appropriate patients and potential barriers to adherence, and learn how they can more effectively utilize these therapies in their unique patient population.
Before jumping into the activity content, reflect on what you already know about cardiovascular risk stratification, and strategies for risk improvement, for patients who are overweight or obese.
This module will focus on the clinical benefits of GLP-1 receptor agonists and GLP-1/ GIP receptor agonists and strategies for managing common adverse events.
This module will provide a thorough overview of challenges and benefits of, and indications for, using GLP-1 RAs in cardiology patients with an increased risk for a MACE and who are overweight or obese.
This module focuses on patient-centered approaches for education and follow up regarding GLP-1 and GLP-1/GIP receptor agonists. Learn proven strategies for improving GLP-1 and GLP-1/GIP receptor agonist adherence and long-term outcomes.
Review what you have learned about obesity, CV risk, and using GLP-1 RAs in appropriate patients to mitigate their risk. This short assessment reviews the program’s content and provides new information to enhance your clinical practice.
This Live Group Discussion will focus on a case of a 36-year-old female with atrial fibrillation who hopes to reduce her risk for a cardiac event. We will also address any questions you may have regarding the baseline and final assessments and the self-study modules.
Meet I.K., a 64-year-old male with mild HFpEF, a recent diagnosis of pre-diabetes, and a long history of obesity.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with obesity and increased cardiac risk.
This Live Group Discussion will focus on a case of a 70-year-old male with multiple cardiac risk factors who wants to aggressively reduce his cardiac risk. We will also review your submissions on the Patient Case Challenge and Action Plans.
